When stratified by administration route, the average percentage reductions were: Intramuscular (IM): 48.3% Sublingual: 30.7% Oral: 30.3% These results suggest that IM administration leads the most pronounced homocysteine reduction, however, sublingual and oral routes also demonstrate clinically relevant effects
Regular monitoring, dose adjustments, and medical guidance throughout your therapy journey
Treatment should always be provided by a qualified healthcare professional, with dosage and frequency tailored to individual needs
If you proceed, measure baseline TSH and free T4 and recheck labs 48 weeks after starting
Severity of presentation depends on: Percentage of MetHb Rate of increase in MetHb levels The intrinsic ability of the patient to prevent or reduce MetHb The patients underlying functional status Symptoms depend on the level of MHb and its rapidity of formation, and include: 12 Dyspnea Anxiety Headache Fatigue Weakness CNS depression Dizziness Cyanosis Seizures Signs include: Cyanosis: As little as 1.5 g methemoglobin in 100 ml blood (1.5 g%) can produce clinically recognizable cyanosis